| ALCON AG NAM. SF -,04 |
| Schweiz |
| Gesundheit |
| CH0432492467 / A2PDXE |
| 2U3 (Frankfurt) / ALC (NYSE) |
| FRA:2U3, ETR:2U3, 2U3:GR, NYSE:ALC |
| SMI |
| https://www.alcon.com/ |
|
Alcon Inc. is a leading global vision care company specializing in the development, manufacture, and marketing of surgical equipment, devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. Originally..
>Volltext.. |
| 31749.72 Mio. EUR |
| 34848.83 Mio. EUR |
| 9291.97 Mio. EUR |
| 2399.65 Mio. EUR |
| 886.01 Mio. EUR |
| 1.8 EUR |
| 4472.98 Mio. EUR |
| 1301.99 Mio. EUR |
| 1953.4 Mio. EUR |
| 0.53 |
| -0.13% |
| -7.18% |
| - |
| 0.48% |
| 0.49% |
| 10.05.23 - 0.22703099€ 03.05.22 - 0.21622€ >weitere anzeigen... |
| - |
| ALCON |
| 06.05.26 |
|
||||
|
||||
|